[1]
N. T. T. . Hường and H. M. . Thắng, “Factors related to the outcomes of adjuvant capecitabin monotherapy for high-risk stage II colon cancer”, TCNCYH, vol. 182, no. 9, pp. 105-111, Oct. 2024.